Billionaires Holding FATE

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 20.6M
    Shares Outstanding

  • 48.49M
    Market Cap

News & Insights

ABOUT

FATE

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United States.

Introducing The New Elon Musk Strategy

NEWS

iBillionaire Joins Forces With IBM Watson

READ MORE